Hematological Disorders Associated With COVID-19 Infection

NCT05677750 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-01-10

No results posted yet for this study

Summary

The emergence of the Coronavirus Disease -19 (COVID-19) pandemic, has had a tremendous global impact, resulting in substantial morbidity and mortality worldwide.

Although involvement of the lower respiratory track accounts for most of the morbidity and mortality seen, the virus involves several organ systems and the syndrome exhibits clinical diversity with a wide range of symptoms and manifestations.

Aim of this study is to evaluate if there is a casual relationship between the development of aplastic anemias\& other immune cytopenias, and recent COVID-19 infection.

Conditions

  • Hematological Condition With COVID19

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Mai AA Ahmed, MD · Assiut University

  • Mervat A Amin, MD · Assiut University

  • Mustafa M Embaby, MD · Assiut University

  • Khalid E Elsayh, MD · Assiut University

  • Dalia T Kamel, MD · Assiut University

  • Ebtisam SA Hassanin, MD · Assiut University

  • Hyam Hassan, MD · Assiut University

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-07-30
Completion
2022-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05677750 on ClinicalTrials.gov